| Literature DB >> 23533372 |
Bassem A Al-Maythalony1, M Monim-Ul-Mehboob, Mohammed I M Wazeer, Anvarhusein A Isab, M Nasiruzzaman Shaikh, Saleh Altuwaijri.
Abstract
The synthesis and characterization of cadmium and mercury complexes of selenocyanate of the type [(L)M(SeCN)2] are described, where L is L-Histidine (His) or L-Glycine (Gly) and M is Cd(2+) or Hg(2+). These complexes are obtained by the reaction of 1 equivalent of respective amino acids with metal diselenocyanate precursor in a mixture of solvents (methanol : water = 1 : 1). These synthesized compounds are characterized by analytical and various spectroscopic techniques such as elemental analysis (EA), IR, H,1 and C13 NMR in solution and in the solid state for C13 and N15. The in vitro antibacterial activities of these complexes have been investigated with standard type cultures of Escherichia coli (MTCC 443), Klebsiella pneumoniae (MTCC 109), Pseudomonas aeruginosa (MTCC 1688), Salmonella typhi (MTCC 733), and Staphylococcus aureus (MTCC 737).Entities:
Year: 2013 PMID: 23533372 PMCID: PMC3600247 DOI: 10.1155/2013/476874
Source DB: PubMed Journal: Bioinorg Chem Appl Impact factor: 7.778
13C NMR chemical shifts of Hg(SeCN)2 and Cd(SeCN)2 complexes in DMSO-d 6.
| Species | SeCN | C=O | C-1 | C-2 | C-3 | C-4 | C-5 |
|---|---|---|---|---|---|---|---|
| His | — | 174.7 | 136.2 | 135.0 | 117.9 | 55.1 | 29.0 |
| Gly | — | 173.1 | 42.5 | ||||
| Cd(SeCN)2 | 116.9 | ||||||
| (His)Cd(SeCN)2 | 115.4 | 173.0 | 136.6 | 134.5 | 117.0 | 53.5 | 28.1 |
| (Gly)Cd(SeCN)2 | 119.0 | 194.9 | |||||
| Hg(SeCN)2 | 103.3 | ||||||
| (His)Hg(SeCN)2 | 109.8 | 170.3 | 135.0 | 132.3 | 116.4 | 53.3 | 27.4 |
| (Gly)Hg(SeCN)2 | 116.5 | 189.2 |
77Se NMR chemical shifts of Hg(SeCN)2 and Cd(SeCN)2 complexes in DMSO-d 6.
| Species | 77Se (in ppm) |
|---|---|
| Cd(SeCN)2 | −272.94 |
| Hg(SeCN)2 | −109.18 |
| (His)Hg(SeCN)2 | −169.71 |
Elemental analysis of the prepared complexes.
| Complex | M. Pt. (C) | Found (Calcd.)% | ||
|---|---|---|---|---|
| H | C | N | ||
| (Gly)Cd(SeCN)2 | Decomp. at 184 | 1.32 (1.27) | 12.15 (12.09) | 10.78 (10.57) |
| (Gly)Hg(SeCN)2 | >300 | 1.10 (1.04) | 10.04 (9.89) | 9.00 (8.65) |
| (His)Cd(SeCN)2 | Decomp. > 205 | 2.00 (1.90) | 20.44 (20.12) | 14.88 (14.67) |
| (His)Hg(SeCN)2 | Decomp. > 140 | 1.70 (1.60) | 17.11 (16.99) | 12.64 (12.38) |
Figure 3Possible binding sites for Cd2+ and Hg2+ His and Gly complexes.
IR frequencies, ν(cm−1) Hg(SeCN)2 and Cd(SeCN)2 complexes theoretical versus experimental.
| Species |
|
|
|
|
|
|
|---|---|---|---|---|---|---|
| KSeCN | — | — | 2070a | — | — | — |
| L-Gly | 1606 s | — | — | — | 3424 | — |
| L-Hist | 1634 s | — | — | — | 3127 | — |
| Cd(SeCN)2 | — | — | 2107 | — | — | — |
| (L-Gly)Cd(SeCN)2 | 1611 s | 1759 | 2107 | 2127 | 3450 | 3455 |
| (L-Hist)Cd(SeCN)2 | 1631 s | 1718 | 2109 | 2112 | 3460 | 3402 |
| Hg(SeCN)2 | — | — | 2127 | — | — | — |
| (L-Gly)Hg(SeCN)2 | 1611 s | 1742 | 2130 | 2137 | 3447 | 3476 |
| (L-Hist)Hg(SeCN)2 | 1636 s | 1716 | 2111 | 2118 | 3422 | 3423 |
a[14].
Solid-state 13C Isotropic Chemical Shifts (δ iso) and Principle Shielding Tensors(σ )a of complexes Cd(II)-Selenocyanate complexes with Glycine and Histidine ligands.
| Complex | Nucleus |
|
|
|
| Δ |
|
|---|---|---|---|---|---|---|---|
| Cd(SeCN)2 | 113Cd | 211.9 | 322 | 283 | 30 | 291 | 0.73 |
| 77Se | −119.6 | 53 | 41 | −452 | 505 | 0.96 | |
| 13C | 117.0 | 222 | 205 | −76 | 298 | 0.89 | |
|
| |||||||
| (Gly)Cd(SeCN)2 | 13C | 170.8 | 242 | 171 | 98 | −109 | 0.98 |
| 13C | 119.9 | 212 | 124 | 23 | −146 | 0.90 | |
|
| |||||||
| (His)Cd(SeCN)2 |
13C | 169.3 | 236 | 169 | 102 | −101 | 0.99 |
| 13C | 108.4 | 181 | 103 | 41 | −101 | 0.86 | |
| 13C | 132.0 | 202 | 136 | 58 | −111 | 0.90 | |
| 13C | 129.2 | 196 | 130 | 61 | −102 | 0.96 | |
| 13C | 119.5 | 213 | 120 | 23 | −142 | 0.97 | |
aIsotropic shielding,σ = (σ 11 + σ 22 + σ 33)/3; Δσ = σ 33 − 0.5 (σ 11 + σ 22); η = 3(σ 22 − σ 11)/2Δσ.
Solid-state 15N isotropic chemical shifts (δ iso) and principle shielding tensors (δ )a of complexes, Hg(II)-selenocyanate complexes.
| Complex | Nucleus |
|
|
|
| Δ |
|
|---|---|---|---|---|---|---|---|
| His | 15N | −202.55 | −97.76 | −181 | −328.85 | −189.45 | 0.66 |
| 15N | −331.02 | — | — | — | — | — | |
| (His)Hg(SeCN)2 | 15N | −156.73 | −27.66 | — | −272.80 | −174.11 | 0.80 |
| 15N | −146.5 | — | 169.72 | — | — | — | |
| Gly | 15N | −345.56 | — | — | — | — | — |
| (Gly)Hg(SeCN)2 | 15N | −311.01 | — | — | — | — | — |
aIsotropic shielding, σ : (σ 11 + σ 22 + σ 33)/3; Δσ: σ 33 − 0.5(σ 11 + σ 22); η: 3(σ 22 − σ 11)/2Δσ.
Figure 113C CPMAS spectra of (a) (Gly)Cd(SeCN)2, (b) (His)Cd(SeCN)2. The center peak is denoted by “∗.”
Figure 215N NMR spectra of (a) (Gly)Hg(SeCN)2 and (b) (His)Hg(SeCN)2.
Scheme 1Optimized geometries of [LM(SeCN)2] (a), (b), (c), and (d), obtained at the B3LYP/LanL2DZ level of theory using Gaussian 09, Revision A. 1. L refers to Histidine or Glycine, while M refers to Hg or Cd.
Selected bond lengths (Å) for [LM(SeCN)2] for optimized structure using B3LYP/LanL2DZ; L refers to Histidine and Glycine, while M refers to Hg or Cd.
| Hg(SeCN)2 + His | Cd(SeCN)2 + His | Hg(SeCN)2 + Gly | Cd(SeCN)2 + Gly | ||||
|---|---|---|---|---|---|---|---|
| Hg-Se1 | 2.765 | Cd-Se1 | 2.718 | Hg-Se1 | 2.699 | Cd-Se1 | 2.656 |
| Hg-Se2 | 2.795 | Cd-Se2 | 2.745 | Hg-Se2 | 2.731 | Cd-Se2 | 2.691 |
| Hg-N1 | 2.434 | Cd-N1 | 2.302 | Hg-N1 | 2.576 | Cd-N1 | 2.415 |
| Hg-N2 | 2.537 | Cd-N2 | 2.399 | Hg-O1 | 2.656 | Cd-O1 | 2.423 |
| C=O | 1.236 | C=O | 1.236 | C=O | 1.232 | C=O | 1.228 |
| C–O | 1.386 | C–O | 1.386 | C–O | 1.402 | C–O | 1.412 |
Selected torsion angle (°) for [LM(SeCN)2] for optimized structure using B3LYP/LanL2DZ; L refers to Histidine and Glycine, while M refers to Hg or Cd.
| Hg(SeCN)2 + His | Cd(SeCN)2 + His | Hg(SeCN)2 + Gly | Cd(SeCN)2 + Gly | ||||
|---|---|---|---|---|---|---|---|
| Se1-C-N4 | 178.79 | Se1-C-N4 | 178.45 | Se1-C-N3 | 178.03 | Se1-C-N2 | 178.20 |
| Se2-C-N5 | 176.36 | Se2-C-N5 | 175.84 | Se2-C-N2 | 177.04 | Se2-C-N3 | 176.32 |
| N1-Hg-N2 | 83.87 | N1-Cd-N2 | 87.79 | N1-Hg-O1 | 64.67 | N1-Cd-O1 | 96.81 |
| Se1-Hg-Se2 | 125.79 | Se1-Cd-Se2 | 121.32 | Se1-Hg-Se2 | 149.92 | Se1-Cd-Se2 | 139.71 |
| Se1-Hg-N1 | 108.92 | Se1-Cd-N1 | 111.15 | Se1-Hg-N1 | 107.50 | Se1-Cd-N1 | 112.35 |
| Se2-Hg-N2 | 99.18 | Se2-Cd-N2 | 101.26 | Se2-Hg-O1 | 111.58 | Se2-Cd-O1 | 112.17 |
| Se1-Hg-N2 | 118.69 | Se1-Cd-N2 | 116.85 | Se1-Hg-O1 | 89.99 | Se1-Cd-O1 | 96.81 |
| Se2-Hg-N1 | 112.60 | Se2-Cd-N1 | 113.30 | Se2-Hg-N1 | 100.81 | Se2-Cd-N1 | 103.86 |
Antibacterial activities of [LM(SeCN)2] complexes.
| Microorganisms | Zone of inhibition (mm) | |||
|---|---|---|---|---|
| Hg(SeCN)2* | Cd(SeCN)2 | (His)Cd(SeCN)2 | (Gly)Cd(SeCN)2 | |
|
| — | 25 | 35 | 22 |
|
| 10 | 20 | 18 | 32 |
|
| 10 | 28 | 32 | 29 |
|
| 22 | 20 | 22 | 20 |
|
| 22 | — | — | — |
*[15]